Abstract
Saliva proteins may protect older people from influenza, however, it is often noted that hospitalizations and deaths after an influenza infection mainly occur in the elderly population living with chronic diseases, such as diabetes and cancer. Our objective was to investigate the expression level of the terminal α2-3- and α2-6-linked sialic acids in human saliva from type 2 diabetes mellitus (T2DM), liver disease and gastric cancer (GC) patients and assess the binding activity of these linked sialic acids against influenza A viruses (IAV). We observed that the expression level of the terminal α2-3-linked sialic acids of elderly individuals with T2DM and liver disease were down-regulated significantly, and the terminal α2-6 linked sialic acids were up-regulated slightly or had no significant alteration. However, in the saliva of patients with GC, neither sialic acid was significantly altered. These findings may reveal that elderly individuals with chronic diseases, such as diabetes and liver disease, might be more susceptible to the avian influenza virus due to the decreased expression of terminal α2-3-linked sialic acids in their saliva.
Highlights
Saliva proteins may protect older people from influenza, it is often noted that hospitalizations and deaths after an influenza infection mainly occur in the elderly population living with chronic diseases, such as diabetes and cancer
The expression of the terminal Siaa2-6Gal recognized by Sambucus Nigra Lectin (SNA) and Siaa2-3Gal recognized by Maackia Amurensis Lectin II (MAL-II) were investigated in human saliva from type 2 diabetes mellitus (T2DM) (Supplementary Table S1), HB, HC, HCC (Supplementary Table S2) and gastric cancer (GC) patients (Supplementary Table S3) using the lectin microarrays
A previous study has shown that chronic obstructive pulmonary disease (COPD), asthma, arthritis, asthma, cancer, diabetes, liver disease, HIV/ AIDS, neurological diseases, and heart and lung diseases can weaken
Summary
Saliva proteins may protect older people from influenza, it is often noted that hospitalizations and deaths after an influenza infection mainly occur in the elderly population living with chronic diseases, such as diabetes and cancer. Our objective was to investigate the expression level of the terminal a2-3- and a2-6-linked sialic acids in human saliva from type 2 diabetes mellitus (T2DM), liver disease and gastric cancer (GC) patients and assess the binding activity of these linked sialic acids against influenza A viruses (IAV). To improve our understanding for the reason why hospitalizations and deaths after an influenza infection mainly occur in the elderly population living with chronic diseases and to find the characteristics of the susceptible population for IVA, we aimed to compare the expression level of the terminal a2-3- and a2-6-linked sialic acids in human saliva from type 2 diabetes mellitus (T2DM), liver disease (hepatitis B (HB), hepatic cirrhosis www.nature.com/scientificreports (HC), hepatocellular carcinoma (HCC)) and gastric cancer (GC) patients and assess the binding activity of these linked sialic acids against IVA
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have